Beijing Hotgen Biotech Co Ltd Class A 688068
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- ¥26.56
- Day Range
- ¥27.10–30.99
- 52-Week Range
- ¥22.94–55.88
- Bid/Ask
- ¥30.12 / ¥30.18
- Market Cap
- ¥2.79 Bil
- Volume/Avg
- 4.1 Mil / 764,492
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 4.95
- Dividend Yield (Trailing)
- 0.75%
- Dividend Yield (Forward)
- 0.75%
- Total Yield
- 0.75%
Company Profile
Beijing Hotgen Biotech Co Ltd is engaged in the development and manufacturing of innovative in-vitro diagnostic, point-of-care-testing and biodefense products.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Value
- Total Number of Employees
- 1,036
- Website
- http://www.hotgen.com.cn
Comparables
Valuation
Metric
|
688068
|
688253
|
603392
|
---|---|---|---|
Price/Earnings (Normalized) | — | 19.62 | 85.49 |
Price/Book Value | 0.77 | 2.70 | 7.57 |
Price/Sales | 4.95 | 8.00 | 34.36 |
Price/Cash Flow | — | 15.34 | 402.76 |
Price/Earnings
688068
688253
603392
Financial Strength
Metric
|
688068
|
688253
|
603392
|
---|---|---|---|
Quick Ratio | 3.29 | 15.40 | 3.81 |
Current Ratio | 6.88 | 15.84 | 4.48 |
Interest Coverage | −253.76 | 2,238.82 | −59.06 |
Quick Ratio
688068
688253
603392
Profitability
Metric
|
688068
|
688253
|
603392
|
---|---|---|---|
Return on Assets (Normalized) | −5.33% | 12.17% | −3.06% |
Return on Equity (Normalized) | −5.67% | 13.13% | −3.76% |
Return on Invested Capital (Normalized) | −6.61% | 12.68% | −4.05% |
Return on Assets
688068
688253
603392
Biotechnology Industry Comparables
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
---|---|---|---|---|---|---|
Novo Nordisk AS ADR
NVO
| Yqxhsdmph | Sffz | $531.4 Bil | |||
Vertex Pharmaceuticals Inc
VRTX
| Twblrzh | Sqpgsg | $119.5 Bil | |||
Regeneron Pharmaceuticals Inc
REGN
| Pbjqcckg | Vdzyvc | $114.9 Bil | |||
Alnylam Pharmaceuticals Inc
ALNY
| Mthrxhsqf | Hfmsxtf | $35.3 Bil | |||
argenx SE ADR
ARGX
| Mwtqphxc | Glbml | $32.0 Bil | |||
BioNTech SE ADR
BNTX
| Cjrymlxw | Pyd | $28.1 Bil | |||
Moderna Inc
MRNA
| Hrzhvcms | Brlw | $25.3 Bil | |||
United Therapeutics Corp
UTHR
| Yknkxrk | Dqjw | $16.0 Bil | |||
Biomarin Pharmaceutical Inc
BMRN
| Bzgwjyv | Tkqhm | $13.4 Bil | |||
Incyte Corp
INCY
| Tsywnwh | Ppfzy | $12.7 Bil |